Patent · US Active

Use of fibromodulin and lumican for increasing muscle mass

US9175055B2 · kind B2 · utility

0Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 15, 2012
Grant dateNov 3, 2015
Priority date
Expiry dateOct 15, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/705
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the use of fibromodulin and lumican, particularly active fragments thereof, to increase muscle mass, especially in the treatment of muscular dystrophies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.